- Home
- Products
BOSULIF (Bosutinib)
BOSULIF (Bosutinib)
- Medicine Name: Bosulif
- Generic Name: Bosutinib
- Dosage Form & Strength: Tablets – 100 mg, 400 mg, 500 mg | Capsules – 50 mg, 100 mg
- Manufactured By: Pfizer
Bosulif (bosutinib) is a tyrosine kinase inhibitor used for the treatment of Philadelphia chromosome-positive (Ph+) chronic myelogenous leukemia (CML). It is indicated for:
Adults and children (1 year and older) with newly diagnosed chronic phase Ph+ CML
Adults with chronic, accelerated, or blast phase Ph+ CML who are resistant or intolerant to prior therapy
Recommended Dosage:
- Adults (newly diagnosed CP Ph+ CML): 400 mg once daily with food
- Adults (resistant/intolerant CP/AP/BP Ph+ CML): 500 mg once daily with food
- Pediatric Patients:
- Newly diagnosed CP Ph+ CML: 300 mg/m² once daily with food
- Resistant/intolerant CP Ph+ CML: 400 mg/m² once daily with food
Administration Guidelines: - Take with food; swallow tablets or capsules whole
- If using capsules and swallowing is an issue, they may be mixed with applesauce or yogurt (do not replace a full meal)
- If a dose is missed by more than 12 hours, skip the dose and resume at the next scheduled time
Gastrointestinal Disturbances: May cause nausea, vomiting, diarrhea, or abdominal pain. Stay hydrated and consult a doctor if symptoms persist.
Low Blood Cell Counts: May lead to infections, bleeding, or anemia. Regular CBC monitoring is necessary.
Liver Function: May elevate liver enzymes. Monitor liver function tests regularly.
Cardiac Risk: Potential to cause arrhythmias or heart failure. Report symptoms like chest pain or swelling promptly.
Fluid Retention: May lead to swelling of the hands, feet, or face. Inform your physician if swelling or rapid weight gain occurs.
Renal Impact: Can cause reduced kidney function; kidney tests should be performed routinely.
Pregnancy Risk: Bosulif can harm an unborn baby. Women should use effective contraception during treatment.
Breastfeeding: Not recommended while on treatment. Consult your doctor for safer alternatives.
To Import Bosulif into India, you will need:
- A valid prescription from a registered oncologist
- Diagnostic test reports
- Government-issued ID proof of the patient
Order Confirmation:
Orders are processed only upon receiving the above documentation and, if required, an import permit.
Availability in India:
Bosulif is not commercially available in Indian pharmacies. GlobalRareMeds facilitates legal access through the Named Patient Import Program, helping patients receive the medication from trusted international sources.
GlobalRareMeds sources Bosulif (Bosutinib) from licensed suppliers in the USA, Canada, Europe, and Australia.
Orders are shipped from our certified logistics hub in Ambernath, Thane District, with delivery support across India including Mumbai, Delhi, Bengaluru, Hyderabad, Chennai, Kolkata, Pune, and Ahmedabad.
Contact us to place an order or request pricing:
📧 info@globalraremeds.com
📞 +91-99675 15602
📱 WhatsApp: +91-99675 15602
What is the generic name for Bosulif?
Bosutinib.
Who manufactures Bosulif?
Pfizer.
Is Bosulif FDA approved?
Yes, Bosulif was approved by the U.S. FDA on September 4, 2012.
In what forms and strengths is Bosulif available?
Bosulif is available as tablets (100 mg, 400 mg, 500 mg) and capsules (50 mg, 100 mg).
What are the common side effects?
Nausea, vomiting, diarrhea, abdominal pain, rash, fatigue, liver enzyme elevation, headache, decreased appetite, and respiratory infections.
Where can I buy Bosulif in India at the best price?
Contact GlobalRareMeds with a valid prescription to get Bosulif imported at a competitive price.
Is Bosulif available in SAARC countries?
Yes. We assist in supplying Bosulif to Afghanistan, Bangladesh, Bhutan, Maldives, Nepal, Pakistan, and Sri Lanka.
Is it safe to buy Bosulif online in India?
Yes, provided the purchase is made through a legal importer like GlobalRareMeds with valid documentation and approvals.
What are the storage conditions for Bosulif?
Store at 20°C to 25°C (68°F to 77°F). Permissible temperature excursions: 15°C to 30°C. Keep in original packaging to protect from moisture and light.
Contact Patient Support
If you have questions about your order, need assistance with documentation, or require support with medicine availability, our GlobalRareMeds Patient Support Team is here to help. We aim to respond within 24 hours, Monday to Friday, between 9:00 AM and 10:00 AM IST.
info@globalraremeds.com
Phone
+91 99675 15602
+91 99675 15602
Disclaimer
All trademarks, brands, and product names featured on this website are the property of their respective owners. GlobalRareMeds does not claim ownership or affiliation unless explicitly stated. Our role is to provide reliable and transparent access to difficult-to-source medicines through named-patient import services, based on valid prescriptions and legal requirements.
The product-related content on this website is shared to the best of our knowledge, compiled from publicly available sources and regulatory documents. However, GlobalRareMeds does not guarantee the accuracy, completeness, or timeliness of this information. We strongly recommend that all medical decisions, including usage and dosage, be made only in consultation with the prescribing doctor. GlobalRareMeds assumes no responsibility for consequences arising from reliance on this information without appropriate medical guidance
